Home > Healthcare & Medical Devices > Femtech Market

Femtech Market Size By Type (Products, Software, Services), By Application (Reproductive Health, Pregnancy & Nursing Care, Pelvic & Uterine Healthcare, General Healthcare & Wellness), By End-use (Direct-to-consumer, Hospitals, Fertility Clinics, Surgical Centers, Diagnostic Centers), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Italy, Spain, Russia, Japan, China, India, Australia, Brazil, Mexico, Saudi Arabia, South Africa), Growth Potential, Competitive Market Share & Forecast, 2023 – 2032

  • Report ID: GMI4442
  • Published Date: Dec 2022
  • Report Format: PDF

Industry Statistics

Femtech Market size crossed USD 30 billion in 2022 and is poised to depict over 16% CAGR through 2023-2032. This is a result of the escalating adoption of digitized healthcare solutions and the mounting health burden in underdeveloped regions.
 

Get more details on this report - Request Free Sample PDF
 

With rapid digitalization, femtech is emerging as a prominent trend in the health sector that helps meet the unmet health needs of women. Health tech service providers have been emphasizing the development of advanced devices for minimally invasive and non-invasive procedures. In addition, the rising development of tech-enabled products for improved diagnosis and clinical information delivery will boost the popularity of femtech devices.
 

Rising fertility rate and digitalization to boost requirement for femtech services

Femtech market share from the services type segment will register 15% CAGR through 2023-2032. To optimize fertility treatment and postnatal care, health facilities have been leveraging virtual platforms. These trends are attributed to the general rise in the fertility rate. Based on data from the CDC, in 2021, the U.S. witnessed a 1% increase in the birth rate from 2020, with nearly 3.6 million births recorded. Furthermore, the mounting use of digital platforms and advanced products to improve health service delivery and patient outcomes will drive femtech service demand.

 

Get more details on this report - Request Free Sample PDF
 

Increasing incidences of uterine cancer & PIDs to bolster femtech product development

Femtech market from pelvic & uterine healthcare applications are expected to account for over 18% business share by 2032. The growing awareness of the impact of pelvic inflammatory diseases on fertility and reproductive health is a major factor driving the usage of femtech products. As per a CDC report, 1 in 8 women with PIDs has trouble conceiving. Uterine cancer has also become a common gynecologic cancer, with new cases continuing to rise across the U.S. These factors will thus promote the use of femtech solutions for pelvic and uterine healthcare.
 

High chronic disease prevalence spurs femtech use in diagnostic centers

Get more details on this report - Request Free Sample PDF
 

Based on end-use, the diagnostic centers segment is projected to hold over 8% share of the femtech market by 2032. This is on account of the advent of telehealth tools and other digital health technologies to enhance care and reduce patient visits. The prevalence of chronic diseases has also surged over the years. According to WHO estimates, by 2025, nearly 167 million people will become overweight or obese. Since obesity is associated with a range of female reproductive disorders, the high burden of this condition is likely to fuel demand for femtech products in diagnostic centers.
 

Mounting healthcare spending to support growth of European femtech product developers

Get more details on this report - Request Free Sample PDF
 

Europe femtech market is anticipated to cross USD 35 billion by 2032, due to the strong presence of femtech product developers in the region. Government healthcare spending has also accelerated over recent years. Based on statistics from Eurostat, in 2020, general government expenditure on health amounted to over USD 1,133 billion, or 8% of the GDP, in the EU. These factors, along with the expansion of medical manufacturing, will create lucrative prospects for femtech device manufacturers across the region.
 

Strategic partnerships among key players to strengthen the industry landscape

The competitive landscape of the femtech market comprises companies such as BioWink GmbH, Athena Feminine Technologies, Conceivable, Inc, HeraMED, Elvie, iSono Health, Nuvo Cares, Minerva Surgical, Prelude, Sustain Natural, Sera Prognostics, Univfy, and Totohealth, among others. These companies are incorporating strategies such as collaborations, acquisitions, and product range expansions to reinforce their footprint in the market.
 

Impact of COVID-19 pandemic on femtech industry dynamics

The healthcare sector has been witnessing a steep increase in patient reliance on remote monitoring services and digital health solutions to limit hospital visits and coronavirus exposure. Since the onset of the COVID-19 pandemic, women also have been facing increased concerns regarding their health status. Due to lifestyle changes, the risk of developing mental, metabolic, and chronic diseases has also surged significantly. These factors will promote remote healthcare monitoring through the use of femtech apps among women and consequently expedite industry development over the forecast period.
 

The femtech market report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD million from 2018 to 2032 for the following segments:

By Type

  • Products
  • Software
  • Services

By Application

  • Reproductive Health
  • Pregnancy & Nursing Care
  • Pelvic & Uterine Healthcare
  • General Healthcare & Wellness
  • Others

By End-use

  • Direct-to-consumer
  • Hospitals
  • Fertility Clinics
  • Surgical Centers
  • Diagnostic Centers
  • Others

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Spain
    • Italy
    • Russia
    • Others
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
    • South Africa
    • Saudi Arabia
    • Others

 

Authors: Sumant Ugalmugle, Rupali Swain

Frequently Asked Questions (FAQ) :

Global market for femtech exceeded USD 30 billion in 2022 and is poised to depict over 16% CAGR through 2023-2032, due to the escalating adoption of digitized healthcare solutions.
Services type segment will register a 15% CAGR through 2023-2032, as a result of the rising fertility rate and virtual health platform adoption.
Europe femtech market is anticipated to cross USD 35 billion by 2032, due to mounting government health spending and medical manufacturing expansion.
BioWink GmbH, Athena Feminine Technologies, Conceivable, Inc, HeraMED, Elvie, iSono Health, Nuvo Cares, Minerva Surgical, Prelude, Sustain Natural, Sera Prognostics, Univfy, and Totohealth are among the key players operating in the market.

Buy Now


Premium Report Details

  • Base Year: 2022
  • Companies covered: 14
  • Tables & Figures: 193
  • Countries covered: 16
  • Pages: 145
  • Upcoming Report: Details can be customized to meet your information and data needs. Feel free to share your detailed research requirements via this form.

Get a report that explains COVID-19 impact on this market

 Request Free Sample

Budget constraints? Get in touch with us for special pricing

Request Discount